Diabetes Mellitus: Promoting Collaboration among Health Care Professionals

References

1. Centers for Disease Control and Prevention. National diabetes fact sheet: general information and national estimates on diabetes in the United States, 2007. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, 2008.
2. National Institute of Diabetes and Digestive and Kidney Diseases. National Diabetes Statistics fact sheet: general information and national estimates on diabetes in the United States, 2005.Bethesda, MD: U.S. Department of Health and Human Services, National Institutes of Health, 2005.
3. 1. Little JW,
   2. Falace DA,
   3. Miller CS,
   4. Rhodus NL

   . Dental management of the medically compromised patient, 7th ed. 2008. St.Louis: Mosby Elsevier, 212–235.
4. 1. Nathan DM,
   2. Cleary PA,
   3. Backlund JY,
   4. et al

   . Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med. 2005;353:2643–2653.

   OpenUrlCrossRefPubMedWeb of Science
5. 1. Mensinger C

   . Diagnosis and classification of diabetes mellitus. Diabetes Care. 2006;29(Suppl 1):S43–S48.

   OpenUrlFREE Full Text
6. 1. Kumar V,
   2. Abbas AK,
   3. Fausto N

   . Robbins and Cotran pathologic basis of disease, 7th ed. 2005. Philadelphia: Elsevier Saunders, 1189–1207.
7. 1. Mensing C

   . Standards of medical care in diabetes - 2006. Diabetes Care. 2006;29(suppl 1):S4–S42.

   OpenUrlFREE Full Text
8. 1. Knowler WC,
   2. Barrett-Connor E,
   3. Fowler SE,
   4. Hamman RF,
   5. et al

   . Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346:393–403.

   OpenUrlCrossRefPubMedWeb of Science
9. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Eng J Med. 1993;329:977–86.

   OpenUrlCrossRefPubMedWeb of Science
10. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. (UKPDS) Group. Lancet. 998;352:837–53.
11. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes. IKPDS 38. UK Prospective Diabetes Study Group. BMJ. 1998;317:703–13.

    OpenUrlAbstract/FREE Full Text
12. 1. Goldberg RB,
    2. Mleeies MJ,
    3. Sacks FM,
    4. Moyé LA,
    5. et al

    . Cardiovascular events and their reduction with pravastatin and diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels; Subgroup analyses in the cholesterol and recurrent events (CARE) trial. The Care Investigators. Circulation. 1998;98:2513–9.

    OpenUrlAbstract/FREE Full Text
13. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus. Results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators. Lancet. 2000;355:253–9.

    OpenUrlCrossRefPubMedWeb of Science
14. 1. Schwartz JS,
    2. Boccuzzi SJ,
    3. Glick H,
    4. Cook JR,
    5. et al

    . Cost-effectiveness of LDL-C reduction in diabetic CHD patients:Implications from the Scandinavian Simvastatin Survival Study (4S). Circulation. 1997;96(Suppl 1):1504–5 [Abstract].

    OpenUrl
15. 1. Sack K

    : Doctors miss cultural needs, study says. The New York Times. June 10, 2008. Available at http://www.nytimes.com/2008/06/10/health/10study.html. Accessed June 10, 2008.
16. Centers for Disease Control and Prevention. Working Together to Manage Diabetes: A Guide for Pharmacists, Podiatrists, Optometrists, and Dental Professionals. Atlanta, GA: U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, 2007.
17. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. “Retinopathy and Nephropathy in Patients with Type 1 Diabetes Four Years After a Trial of Intensive Therapy.” N Engl J Med. 2000;342: 381–89.

    OpenUrlCrossRefPubMedWeb of Science
18. 1. Kempen J.H.,
    2. et al

    . “The Prevalence of Diabetic Retinopathy Among Adults in the United States.” Archives of Ophthalmology 2004;122.4: 552–63.

    OpenUrl
19. 1. Ashton N

    : Studies of the retinal capillaries in relation to diabetic and other retinopathies. Br J Ophthalmology. 1963;47:521–538.

    OpenUrlFREE Full Text
20. 1. Fong D.S.,
    2. et al

    . “American Diabetes Association. Retinopathy in Diabetes.” Diabetes Care. 2004; 27 (suppl. 1): S4–87.

    OpenUrl
21. 1. Moss S.E.,
    2. Klein R.,
    3. Klein B.E.

    . “The 14-year Incidence of Visual Loss in a Diabetic Population.” Ophthalmology. 1998;105.6:998–1003.

    OpenUrl
22. The Diabetic Retinopathy Study Research Group. Photocoagulation treatment of proliferative diabetic retinopathy: clinical applications of Diabetic Retinopathy Study (DRS) findings: DRS Report Number 8. Ophthalmology. 1981;88:583–600.

    OpenUrlPubMedWeb of Science
23. The Diabetic Retinopathy Vitrectomy Study Research Group. Early vitrectomy for severe vitreous hemorrhage in diabetic retinopathy: DRVS Report Number 5. Arch Ophthalmol.1990;108:958–964.

    OpenUrlCrossRefPubMedWeb of Science
24. Early Treatment Diabetic Retinopathy Study Research Group. Early photocoagulation for diabetic retinopathy: ETDRS Report Number 9. Ophthalmology. 1991;98(suppl): 767–785.

    OpenUrl
25. ETDRS Research Group. Photocoagulation for diabetic macular edema. ETDRS Report Number 1. Arch Ophthalmol. 1985;103:1796–1806.

    OpenUrlCrossRefPubMedWeb of Science
26. 1. Ramsey SD,
    2. Newton K,
    3. Blough D,
    4. et al

    . Incidence, outcomes, and cost of foot ulcers in patients with diabetes. Diabetes Care. 1999;22:382–387.

    OpenUrlAbstract
27. 1. Currie CJ,
    2. Morgan CL,
    3. Peters JR

    : The epidemiology and cost of inpatient care for peripheral vascular disease infection, neuropathy and ulceration in diabetes. Diabetes Care. 1998;21:42–48.

    OpenUrlAbstract/FREE Full Text
28. 1. King H,
    2. Aubert RD,
    3. Herman WH

    . Global burden of diabetes, 1995-2025: prevalence, numerical estimates and projections. Diabetes Care. 1998; 21:1414–31.

    OpenUrlAbstract/FREE Full Text
29. 1. Laing P

    . The development and complications of diabetic foot ulcers. American Journal of Surgery. 1998;76:5S–10S.

    OpenUrl
30. 1. Jeffcoate WJ,
    2. Harding KG

    . Diabetic Foot Ulcers. Lancet. 2003;361-1545–1551.

    OpenUrlCrossRefPubMedWeb of Science
31. 1. Armstrong DJ,
    2. Lavery LA,
    3. Harkless LB

    : Treatment-based classification system for assessment and care of diabetic feet. JAPMA. 1996;86:311–316.

    OpenUrlPubMedWeb of Science
32. 1. Kannel WB,
    2. McGee DL

    : Diabetes and cardiovascular disease: the Framingham Study. J Am Med Assoc. 1979;241: 2035–2038.

    OpenUrlCrossRefPubMedWeb of Science
33. 1. Akbari CM,
    2. Pomposelli FB,
    3. Gibbons GW,
    4. Campbell DR,
    5. Pulling MC,
    6. Mydlarz D,
    7. LoGerfo FW

    : Lower extremity revascularization in diabetes. Arch Surg. 2000; 135:452–456.

    OpenUrlCrossRefPubMedWeb of Science
34. 1. Armstrong DG,
    2. Nguyen HC,
    3. Lavery LA,
    4. VanSchie CHM,
    5. Boulton AJM,
    6. Harkless LB

    , Off-Loading the Diabetic Foot Wound: A randomized clinical trial: Diabetes Care. 2001;24(6):1019–1022.

    OpenUrlAbstract/FREE Full Text
35. 1. Armstrong DG,
    2. Lavery LA,
    3. Sariaya M,
    4. Ashry H

    . Leukocytosis is a poor indicator of acute osteomyelitis of the foot in diabetes mellitus. JFAS. 1996; 35:281.

    OpenUrl
36. 1. Lipsky BA,
    2. Berendt AR,
    3. Deery HG,
    4. et al

    . Diagnosis and treatment of diabetic foot infections. Clin Infect Dis. 2004;39(7):885–910.

    OpenUrlFREE Full Text
37. 1. Vernillo AT

    : Diabetes mellitus: relevance to dental treatment. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001;91(3):263–270.

    OpenUrlCrossRefPubMed
38. 1. Southerland JH,
    2. Taylor GW,
    3. Offenbacher S

    . Diabetes and periodontal infection: making the connection. Clinical Diabetes. 2005:23(4):171–178.

    OpenUrlAbstract/FREE Full Text
39. 1. Löe H

    . Periodontal disease: the sixth complication of diabetes mellitus. Diabetes Care. 1993;16(1):329–34.

    OpenUrlAbstract/FREE Full Text
40. 1. Mealey BL,
    2. Oates TW

    . Diabetes mellitus and periodontal diseases. J Periodontol. 2006;77:1289–1303.

    OpenUrlCrossRefPubMedWeb of Science
41. U.S. Department of Health and Human Services. Oral Health in America: A Report of the Surgeon General. Rockville, MD: U.S. Department of Health and Human Services, National Institutes of Health, National Institute of Dental and Craniofacial Research, 2000.
42. 1. Taylor GW

    . Bidirectional interrelationships between diabetes and periodontal diseases: An epidemiologic perspective. Ann Periodontol. 2001;6(1):99–112.

    OpenUrlCrossRefPubMed
43. 1. Grossi SG,
    2. Genco RJ

    . Periodontal disease and diabetes mellitus: Two-way relationship. Ann Periodontol. 1998;3(1):51–61.

    OpenUrlCrossRefPubMed
44. 1. Grossi SG,
    2. Skrepcinski FB,
    3. DeCaro T,
    4. Robertson DC,
    5. et al

    . Treatment of periodontal disease in diabetics reduces glycated hemoglobin. J Periodontol. 1997;68(8):713–9.

    OpenUrlPubMedWeb of Science
45. 1. Taylor GW,
    2. Burt BA,
    3. Becker MP,
    4. Genco RJ,
    5. et al

    . Severe periodontitis and risk for poor glycemic control in patients with non-insulin-dependent diabetes mellitus. J Periodontol. 1996;67(10 Suppl):108S–93.

    OpenUrl
46. 1. Donahue RP,
    2. Wu T

    . Insulin resistance and periodontal disease: An epidemiologic overview of research needs and future directions. Ann Periodontol. 2001;6(1):119–24.

    OpenUrlCrossRefPubMed
47. 1. Ryan ME,
    2. Carnu O,
    3. Kamer A

    . The influence of diabetes on the periodontal tissues. JADA. 2003;134:34S–40S.

    OpenUrlAbstract/FREE Full Text
48. 1. Graves DA,
    2. Al-Mashat H,
    3. Liu R

    . Evidence that diabetes mellitus aggravates periodontal diseases and modified the response to an oral pathogen in animal models. Compend Contin Ed Dent. 2004; 25(7) (Suppl 1):38–46.

    OpenUrl
49. 1. Saydah SH,
    2. Fradkin J,
    3. Cowie CC

    . Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. JAMA. 2004;291(3):335–342.

    OpenUrlCrossRefPubMedWeb of Science
50. 1. Galt KA

    . Cost avoidance, acceptance, and outcomes associated with a pharmacotherapy consult clinic in a Veterans Affairs Medical Center. Pharmacotherapy. 1998;8(5):1103–11.

    OpenUrl
51. 1. Bluml BM,
    2. McKenney JM,
    3. Cziraky MJ

    . Pharmaceutical care services and results in project ImPACT: Hyperlipidemia. J Am Pharm Assoc. 2000;40(2):157–65.

    OpenUrlPubMed
52. 1. Tsuyuki RT,
    2. Johnson JA,
    3. Teo KK,
    4. Simpson SH,
    5. et al

    . A randomized trial of the effect of community pharmacist intervention on cholesterol risk management: The Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP). Arch Intern Med. 2002;162(10):1149–55.

    OpenUrlCrossRefPubMedWeb of Science
53. 1. Yeh G,
    2. Eisenberg D,
    3. Davis R,
    4. Phillips R

    . Use of complimentary and alternative medicine among persons with diabetes mellitus: Results of a national survey. Am J Pub Health. 2002;92:1648–52.

    OpenUrlPubMedWeb of Science
54. Centers for Disease Control and Prevention. Diabetes Medication Supplment: Working Together to Manage Diabetes. Atlanta, GA: U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, 2007.
55. Oral and systemic health: consensus statement from an international panel. Inside Dentistry. 2006;2(Special Issue 1):1–9.

    OpenUrl
56. 1. Hein C,
    2. Cobb C,
    3. Iacopino A

    . Report of the independent panel of experts of ‘The Scottsdale Project’. Published as a special supplement to Grand Rounds in Oral-Sys Med. 2007;3.